AMLODIPINE AND VALSARTAN

AMLODIPINE AND VALSARTAN was reported 197 times

AMLODIPINE AND VALSARTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MENINGITIS CANDIDA 3 0.0429
1 ACRAL LENTIGINOUS MELANOMA 1 0.0238
2 ELECTROCARDIOGRAM J WAVE 1 0.0217
3 HEPATIC INFECTION FUNGAL 2 0.0167
4 PROCALCITONIN DECREASED 1 0.0143
5 BLOOD PRESSURE SYSTOLIC 1 0.0135
6 PITUITARY TUMOUR REMOVAL 1 0.0105
7 ORAL LICHENOID REACTION 1 0.0092
8 VULVAR DYSPLASIA 1 0.0084
9 PENILE DISCOMFORT 1 0.0078
10 COCHLEA IMPLANT 1 0.0073
11 BREAST ULCERATION 1 0.0072
12 CONJUNCTIVAL PALLOR 1 0.0055
13 MALIGNANT MELANOMA STAGE III 1 0.0049
14 FAILURE TO SUSPEND MEDICATION 1 0.0048
15 PENILE BLISTER 1 0.0047
16 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 1 0.0041
17 TYMPANIC MEMBRANE DISORDER 1 0.0031
18 ALLERGIC RESPIRATORY SYMPTOM 1 0.0030
19 KERATOACANTHOMA 2 0.0029
20 PHYSICAL DECONDITIONING 7 0.0027
21 PROTEIN URINE 2 0.0022
22 PATIENT UNCOOPERATIVE 1 0.0021
23 BLOOD IRON ABNORMAL 2 0.0020
24 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
25 ARTERIOVENOUS FISTULA SITE COMPLICATION 1 0.0017
26 URETERIC STENOSIS 1 0.0012
27 SEBORRHOEIC DERMATITIS 2 0.0012
28 ELECTROCARDIOGRAM CHANGE 1 0.0011
29 FOREIGN BODY IN EYE 1 0.0010
30 RED BLOOD CELLS URINE POSITIVE 1 0.0010
31 MAJOR DEPRESSION 7 0.0010
32 KIDNEY ENLARGEMENT 1 0.0009
33 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
34 PRURITUS ALLERGIC 1 0.0009
35 INCISION SITE PAIN 1 0.0009
36 HAEMATOMA MUSCLE 1 0.0008
37 IMMUNE-MEDIATED MYOSITIS 2 0.0007
38 PERIPHERAL ARTERY OCCLUSION 1 0.0007
39 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
40 PRECANCEROUS CELLS PRESENT 1 0.0007
41 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
42 PRECANCEROUS SKIN LESION 1 0.0007
43 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
44 INTERCEPTED MEDICATION ERROR 3 0.0006
45 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
46 TERMINAL INSOMNIA 1 0.0006
47 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
48 ADENOCARCINOMA OF COLON 1 0.0005
49 OSTEOPOROTIC FRACTURE 1 0.0005
50 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
51 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
52 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
53 READING DISORDER 1 0.0004
54 PRURITUS GENITAL 1 0.0004
55 WEIGHT ABNORMAL 1 0.0004
56 SEROTONIN SYNDROME 8 0.0004
57 CATHETER SITE HAEMORRHAGE 1 0.0004
58 NASAL DISORDER 1 0.0004
59 NECK INJURY 1 0.0003
60 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
61 CEREBROVASCULAR DISORDER 1 0.0003
62 VULVOVAGINAL DRYNESS 1 0.0003
63 POSTURE ABNORMAL 1 0.0003
64 INJECTION SITE INFECTION 1 0.0003
65 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
66 BK VIRUS INFECTION 1 0.0003
67 LUNG TRANSPLANT 1 0.0003
68 VENOUS THROMBOSIS 1 0.0003
69 BLEPHARITIS 1 0.0002
70 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
71 METASTATIC NEOPLASM 1 0.0002
72 PLATELET COUNT INCREASED 3 0.0002
73 MELANOCYTIC NAEVUS 1 0.0002
74 TUMOUR LYSIS SYNDROME 2 0.0002
75 WHEELCHAIR USER 1 0.0002
76 URINE ABNORMALITY 1 0.0002
77 METABOLIC ACIDOSIS 7 0.0002
78 ISCHAEMIA 1 0.0002
79 LIMB OPERATION 1 0.0002
80 SINUS BRADYCARDIA 2 0.0002
81 FOOT OPERATION 1 0.0002
82 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
83 PROTEIN URINE PRESENT 1 0.0002
84 FLUID INTAKE REDUCED 1 0.0002
85 CORONARY ARTERY STENOSIS 1 0.0002
86 COLORECTAL CANCER STAGE III 1 0.0002
87 DRUG TOLERANCE 1 0.0002
88 POLYARTHRITIS 1 0.0002
89 HYPERTENSIVE CRISIS 2 0.0002
90 HERPES VIRUS INFECTION 1 0.0002
91 BLOOD URIC ACID INCREASED 1 0.0002
92 MADAROSIS 2 0.0002
93 SUICIDE ATTEMPT 10 0.0002
94 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
95 PRE-EXISTING CONDITION IMPROVED 1 0.0002
96 SWELLING OF EYELID 1 0.0002
97 BLOOD SODIUM DECREASED 3 0.0002
98 PHOTOPSIA 1 0.0002
99 PROCTALGIA 1 0.0002
100 HAEMOGLOBIN ABNORMAL 1 0.0002
101 APPETITE DISORDER 1 0.0002
102 METASTASES TO LYMPH NODES 1 0.0001
103 ABNORMAL LOSS OF WEIGHT 1 0.0001
104 EXTRASYSTOLES 1 0.0001
105 INTENTIONAL OVERDOSE 9 0.0001
106 HYDRONEPHROSIS 1 0.0001
107 PAROSMIA 1 0.0001
108 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
109 BASAL CELL CARCINOMA 2 0.0001
110 GASTROINTESTINAL INFLAMMATION 1 0.0001
111 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
112 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
113 FURUNCLE 1 0.0001
114 BLOOD ALBUMIN DECREASED 1 0.0001
115 UTERINE CANCER 1 0.0001
116 MUSCLE DISORDER 1 0.0001
117 BLOOD POTASSIUM INCREASED 2 0.0001
118 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
119 HAIR DISORDER 1 0.0001
120 ACUTE CORONARY SYNDROME 1 0.0001
121 ANURIA 1 0.0001
122 PSYCHOLOGICAL TRAUMA 1 0.0001
123 MYOPATHY 1 0.0001
124 MUSCLE STRAIN 1 0.0001
125 SKIN SWELLING 1 0.0001
126 FACIAL PAIN 1 0.0001
127 THIRST 2 0.0001
128 OROPHARYNGEAL DISCOMFORT 1 0.0001
129 BRAIN NEOPLASM 1 0.0001
130 POISONING DELIBERATE 1 0.0001
131 PROTEINURIA 2 0.0001
132 EYE INFLAMMATION 1 0.0001
133 DIZZINESS POSTURAL 1 0.0001
134 PHARYNGEAL SWELLING 1 0.0001
135 VITREOUS FLOATERS 1 0.0001
136 HYPOTONIA 1 0.0001
137 OVARIAN CYST 1 0.0001
138 POOR QUALITY DEVICE USED 1 0.0001
139 HYPOTHERMIA 1 0.0001
140 NEUTROPHIL COUNT INCREASED 1 0.0001
141 POLLAKIURIA 4 0.0001
142 CARDIO-RESPIRATORY ARREST 4 0.0001
143 PRODUCT ODOUR ABNORMAL 1 0.0001
144 MOUTH ULCERATION 2 0.0001
145 FISTULA 1 0.0001
146 EYELID OEDEMA 1 0.0001
147 SEXUAL DYSFUNCTION 1 0.0001
148 NOCTURIA 1 0.0001
149 HAIR COLOUR CHANGES 1 0.0001
150 SECRETION DISCHARGE 1 0.0001
151 HEPATIC CYTOLYSIS 1 0.0001
152 ANHEDONIA 2 0.0001
153 BEDRIDDEN 1 0.0001
154 HAIR TEXTURE ABNORMAL 1 0.0001
155 MALIGNANT MELANOMA 1 0.0001
156 EXTRA DOSE ADMINISTERED 3 0.0001
157 PRODUCT TASTE ABNORMAL 1 0.0001
158 ACUTE HEPATIC FAILURE 1 0.0001
159 FEELING COLD 2 0.0001
160 DEMENTIA 2 0.0001
161 HEPATOCELLULAR INJURY 1 0.0001
162 ACCIDENTAL UNDERDOSE 1 0.0001
163 PRODUCT SUBSTITUTION ISSUE 4 0.0001
164 SEPTIC SHOCK 3 0.0001
165 SKIN HAEMORRHAGE 1 0.0001
166 IMMUNODEFICIENCY 1 0.0001
167 ECONOMIC PROBLEM 1 0.0001
168 DELUSION 1 0.0001
169 LUNG INFECTION 1 0.0001
170 BLOOD CHOLESTEROL INCREASED 3 0.0001
171 DRUG-INDUCED LIVER INJURY 2 0.0001
172 ARTHRITIS 5 0.0001
173 RESPIRATORY TRACT CONGESTION 1 0.0001
174 HALLUCINATION, AUDITORY 1 0.0001
175 HYPOTHYROIDISM 2 0.0001
176 URINARY RETENTION 2 0.0001
177 BLOOD UREA INCREASED 1 0.0001
178 GASTRIC DISORDER 2 0.0001
179 RASH MACULAR 2 0.0001
180 HYPERKALAEMIA 2 0.0001
181 HEART RATE DECREASED 2 0.0001
182 COLD SWEAT 1 0.0001
183 DRUG INTERACTION 9 0.0001
184 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
185 LYMPHOCYTE COUNT DECREASED 1 0.0001
186 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
187 DRUG ERUPTION 1 0.0001
188 GALLBLADDER DISORDER 1 0.0001
189 TOOTHACHE 1 0.0001
190 C-REACTIVE PROTEIN INCREASED 2 0.0001
191 END STAGE RENAL DISEASE 1 0.0001
192 RESTLESSNESS 2 0.0001
193 BLOOD GLUCOSE ABNORMAL 1 0.0001
194 AGRANULOCYTOSIS 1 0.0001
195 HEPATIC STEATOSIS 1 0.0001
196 BACTERIAL INFECTION 1 0.0001
197 DYSPNOEA EXERTIONAL 2 0.0001
198 FLATULENCE 3 0.0001
199 SLEEP APNOEA SYNDROME 1 0.0001
200 INCREASED APPETITE 1 0.0001
201 CHOLESTASIS 1 0.0001
202 POST PROCEDURAL COMPLICATION 1 0.0001
203 HERNIA 1 0.0001
204 HAEMORRHOIDS 1 0.0001
205 HAEMATOCRIT DECREASED 1 0.0001
206 SPINAL FRACTURE 1 0.0000
207 FULL BLOOD COUNT DECREASED 1 0.0000
208 PRODUCT ADMINISTRATION ERROR 1 0.0000
209 FEEDING DISORDER 1 0.0000
210 OSTEOPOROSIS 2 0.0000
211 HALLUCINATION, VISUAL 1 0.0000
212 ANAEMIA 9 0.0000
213 IMPAIRED WORK ABILITY 1 0.0000
214 ACUTE KIDNEY INJURY 7 0.0000
215 HEPATOTOXICITY 1 0.0000
216 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
217 PANCREATITIS ACUTE 1 0.0000
218 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
219 CHROMATURIA 1 0.0000
220 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
221 PERICARDIAL EFFUSION 1 0.0000
222 HYPERTENSION 9 0.0000
223 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
224 BLOOD PRESSURE FLUCTUATION 1 0.0000
225 BLOOD GLUCOSE DECREASED 2 0.0000
226 HEPATIC CANCER 1 0.0000
227 HYPOGLYCAEMIA 2 0.0000
228 FIBROMYALGIA 1 0.0000
229 AGEUSIA 1 0.0000
230 DIABETES MELLITUS 3 0.0000
231 HYPOPHAGIA 1 0.0000
232 ERECTILE DYSFUNCTION 1 0.0000
233 SKIN ULCER 1 0.0000
234 HAEMATOMA 1 0.0000
235 DEAFNESS 1 0.0000
236 MUSCULOSKELETAL PAIN 2 0.0000
237 GASTRITIS 1 0.0000
238 CARDIAC FAILURE 3 0.0000
239 SKIN LESION 1 0.0000
240 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
241 SEPSIS 4 0.0000
242 HAEMOPTYSIS 1 0.0000
243 PANCYTOPENIA 2 0.0000
244 WOUND 1 0.0000
245 RENAL IMPAIRMENT 3 0.0000
246 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
247 INTENTIONAL DOSE OMISSION 1 0.0000
248 ANGINA PECTORIS 1 0.0000
249 BALANCE DISORDER 3 0.0000
250 DYSSTASIA 1 0.0000
251 ERYTHEMA 7 0.0000
252 ACUTE MYOCARDIAL INFARCTION 1 0.0000
253 RESPIRATORY DISORDER 1 0.0000
254 BLOOD POTASSIUM DECREASED 1 0.0000
255 APHASIA 1 0.0000
256 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
257 EPILEPSY 1 0.0000
258 ADVERSE EVENT 3 0.0000
259 WEIGHT DECREASED 9 0.0000
260 SWELLING 3 0.0000
261 BONE DENSITY DECREASED 1 0.0000
262 PULMONARY EMBOLISM 3 0.0000
263 MOVEMENT DISORDER 1 0.0000
264 NIGHT SWEATS 1 0.0000
265 ATRIAL FIBRILLATION 3 0.0000
266 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
267 FEBRILE NEUTROPENIA 2 0.0000
268 FUNGAL INFECTION 1 0.0000
269 NEOPLASM MALIGNANT 2 0.0000
270 GAIT INABILITY 1 0.0000
271 TYPE 2 DIABETES MELLITUS 1 0.0000
272 URINARY TRACT INFECTION 5 0.0000
273 ILLNESS 3 0.0000
274 DELIRIUM 1 0.0000
275 ABDOMINAL DISTENSION 3 0.0000
276 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
277 MYELOSUPPRESSION 1 0.0000
278 PANIC ATTACK 1 0.0000
279 DYSURIA 1 0.0000
280 INJECTION SITE MASS 1 0.0000
281 EYE SWELLING 1 0.0000
282 THROMBOCYTOPENIA 3 0.0000
283 COLITIS 1 0.0000
284 BLOOD PRESSURE INCREASED 4 0.0000
285 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
286 PYREXIA 9 0.0000
287 PERIPHERAL SWELLING 4 0.0000
288 PLASMA CELL MYELOMA 1 0.0000
289 DISORIENTATION 1 0.0000
290 THROMBOSIS 2 0.0000
291 EMOTIONAL DISTRESS 3 0.0000
292 DRY MOUTH 2 0.0000
293 PSORIATIC ARTHROPATHY 1 0.0000
294 NEUTROPHIL COUNT DECREASED 1 0.0000
295 WITHDRAWAL SYNDROME 1 0.0000
296 CEREBROVASCULAR ACCIDENT 4 0.0000
297 RECTAL HAEMORRHAGE 1 0.0000
298 MYOCARDIAL INFARCTION 4 0.0000
299 CONSTIPATION 5 0.0000
300 INSOMNIA 6 0.0000
301 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
302 THROAT IRRITATION 1 0.0000
303 THERAPY NON-RESPONDER 1 0.0000
304 TINNITUS 1 0.0000
305 HYPOKALAEMIA 1 0.0000
306 COGNITIVE DISORDER 1 0.0000
307 BLOOD GLUCOSE INCREASED 4 0.0000
308 OCULAR HYPERAEMIA 1 0.0000
309 COMA 1 0.0000
310 MIGRAINE 2 0.0000
311 COLORECTAL CANCER 1 0.0000
312 PRODUCTIVE COUGH 1 0.0000
313 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
314 ALOPECIA 4 0.0000
315 PAIN IN EXTREMITY 6 0.0000
316 DRY EYE 1 0.0000
317 LEUKOPENIA 1 0.0000
318 AGGRESSION 1 0.0000
319 SOMNOLENCE 4 0.0000
320 CONDITION AGGRAVATED 6 0.0000
321 PAIN 12 0.0000
322 CHEST DISCOMFORT 2 0.0000
323 NERVOUSNESS 1 0.0000
324 DEPRESSED MOOD 1 0.0000
325 BRADYCARDIA 1 0.0000
326 PLATELET COUNT DECREASED 2 0.0000
327 ASTHENIA 7 0.0000
328 DRUG EFFECT DECREASED 1 0.0000
329 CONFUSIONAL STATE 3 0.0000
330 DISTURBANCE IN ATTENTION 1 0.0000
331 PNEUMONIA 6 0.0000
332 PRURITUS 7 0.0000
333 TREMOR 3 0.0000
334 ARTHROPATHY 1 0.0000
335 INFLUENZA 2 0.0000
336 URTICARIA 3 0.0000
337 NECK PAIN 1 0.0000
338 COUGH 5 0.0000
339 EYE PAIN 1 0.0000
340 ASTHMA 2 0.0000
341 ANXIETY 5 0.0000
342 SEIZURE 2 0.0000
343 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
344 CHILLS 2 0.0000
345 BLADDER CANCER 1 0.0000
346 FEELING ABNORMAL 4 0.0000
347 IRRITABILITY 1 0.0000
348 JOINT SWELLING 2 0.0000
349 PLEURAL EFFUSION 1 0.0000
350 VERTIGO 1 0.0000
351 DISCOMFORT 1 0.0000
352 MUSCLE SPASMS 3 0.0000
353 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
354 CHEST PAIN 3 0.0000
355 VISUAL IMPAIRMENT 2 0.0000
356 EXPOSURE DURING PREGNANCY 1 0.0000
357 MALAISE 7 0.0000
358 GAIT DISTURBANCE 3 0.0000
359 AMNESIA 1 0.0000
360 PSORIASIS 2 0.0000
361 BLOOD PRESSURE DECREASED 1 0.0000
362 HYPOTENSION 3 0.0000
363 PRODUCT QUALITY ISSUE 2 0.0000
364 NEUTROPENIA 2 0.0000
365 HEPATIC ENZYME INCREASED 1 0.0000
366 INJECTION SITE REACTION 1 0.0000
367 SLEEP DISORDER 1 0.0000
368 DIZZINESS 7 0.0000
369 THERAPY INTERRUPTED 1 0.0000
370 MOBILITY DECREASED 1 0.0000
371 RESPIRATORY FAILURE 1 0.0000
372 AGITATION 1 0.0000
373 EPISTAXIS 1 0.0000
374 HYPOAESTHESIA 2 0.0000
375 HOT FLUSH 1 0.0000
376 CHRONIC KIDNEY DISEASE 1 0.0000
377 DECREASED APPETITE 3 0.0000
378 BACK PAIN 3 0.0000
379 ABDOMINAL PAIN 3 0.0000
380 DRUG DOSE OMISSION BY DEVICE 1 0.0000
381 OFF LABEL USE 11 0.0000
382 INJECTION SITE HAEMORRHAGE 1 0.0000
383 PROSTATE CANCER 1 0.0000
384 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
385 DYSPNOEA 7 0.0000
386 CARDIAC ARREST 1 0.0000
387 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
388 RASH 5 0.0000
389 PRODUCT STORAGE ERROR 1 0.0000
390 COVID-19 2 0.0000
391 DRUG WITHDRAWAL SYNDROME 1 0.0000
392 TACHYCARDIA 1 0.0000
393 HEADACHE 7 0.0000
394 ADVERSE DRUG REACTION 1 0.0000
395 SUICIDAL IDEATION 1 0.0000
396 NASOPHARYNGITIS 2 0.0000
397 CARDIAC DISORDER 1 0.0000
398 DYSPHAGIA 1 0.0000
399 DYSPEPSIA 1 0.0000
400 HEART RATE INCREASED 1 0.0000
401 SYNCOPE 1 0.0000
402 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
403 FLUSHING 1 0.0000
404 HAEMOGLOBIN DECREASED 1 0.0000
405 ARTHRALGIA 4 0.0000
406 HAEMORRHAGE 1 0.0000
407 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
408 RHEUMATOID ARTHRITIS 1 0.0000
409 MUSCULAR WEAKNESS 1 0.0000
410 INCORRECT DOSE ADMINISTERED 2 0.0000
411 PALPITATIONS 1 0.0000
412 DISEASE PROGRESSION 1 0.0000
413 DRUG INEFFECTIVE 11 0.0000
414 OEDEMA PERIPHERAL 1 0.0000
415 HYPERHIDROSIS 1 0.0000
416 RENAL FAILURE 1 0.0000
417 DEHYDRATION 1 0.0000
418 DRY SKIN 1 0.0000
419 VISION BLURRED 1 0.0000
420 MEMORY IMPAIRMENT 1 0.0000
421 HOSPITALISATION 1 0.0000
422 FATIGUE 5 0.0000
423 VOMITING 3 0.0000
424 NAUSEA 5 0.0000
425 DIARRHOEA 4 0.0000
426 FALL 2 0.0000
427 ABDOMINAL DISCOMFORT 1 0.0000
428 TOXICITY TO VARIOUS AGENTS 1 0.0000
429 PRODUCT USE ISSUE 1 0.0000
430 ABDOMINAL PAIN UPPER 1 0.0000
431 DEATH 4 0.0000
432 OVERDOSE 1 0.0000
433 WEIGHT INCREASED 1 0.0000
434 DEPRESSION 1 0.0000
435 PRODUCT DOSE OMISSION ISSUE 1 0.0000